Table 2.
Study protocol items of the trial
Study period | ||||||||
---|---|---|---|---|---|---|---|---|
Screening | Procedure | 3 days | 1 month | 3 months | 6 months | 12 months | 24 months | |
Outpatient visit | √ | √ | √ | √ | √ | √ | √ | |
Physical examination | √ | √ | √ | √ | √ | √ | √ | |
Duplex examination | √ | √ | √ | √ | √ | |||
Inclusion criteria | √ | |||||||
Randomization | √ | |||||||
VCSS | √ | √ | √ | √ | √ | √ | ||
Quality of life score – AVVQ | √ | √ | √ | √ | √ | √ | ||
VAS pain score | √ | √ | √ | |||||
Ecchymosis | √ | √ | ||||||
Other adverse events | √ | √ | √ | √ | √ | √ | √ |
VCSS Venous Clinical Severity Score, AVVQ Aberdeen Varicose Vein Questionnaire, VAS Visual Analog Scale